Stock of the Day for November 6, 2024

McKesson Stock Report

McKesson
MCK 90-day performance NYSE:MCK McKesson
Current Price
$822.44
+14.82 (+1.83%)
(As of 02:10 PM ET)
30 Day Performance
6.45%
  
 
90 Day Performance
17.76%
  
 
1 Year Performance
64.69%
  
 
Market Capitalization
$102.30B
P/E Ratio
32.79
Dividend Yield
0.40%

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers. McKesson also offers a range of technology and automation solutions — including pharmacy automation, supply chain management software, and analytics — designed to improve operational efficiency, inventory control and patient safety for its customers. In addition, the firm provides support services such as clinical program management, patient access and adherence services for specialty therapies, and commercial services for biopharma manufacturers.

McKesson serves a broad customer base that includes retail and independent pharmacies, long-term care providers, hospitals and health systems, physician offices and specialty clinics. While its operations are concentrated in the United States and Canada, the company works with global pharmaceutical manufacturers and participates in international supply chain activities. Its business model emphasizes integration between distribution, technology and services to support the delivery of medications and related care.

Led by a corporate management team focused on resilience and technology-enabled solutions, McKesson has leveraged its long history in healthcare distribution to prioritize supply chain reliability, digital transformation and expanded services for specialty and complex therapies. The company’s combination of logistics capabilities, service offerings and health-technology products positions it as a key intermediary in the U.S. healthcare system.

MCK Company Calendar

AUG. 6, 2025
Last Earnings
SEP. 2, 2025
Ex-Dividend for 10/1 Dividend
OCT. 1, 2025
Dividend Payable
OCT. 30, 2025
Today
NOV. 5, 2025
Next Earnings (Estimated)
MAR. 31, 2026
Fiscal Year End

Recent McKesson News

McKesson (NYSE:MCK) Upgraded by Zacks Research to Strong-Buy Rating
McKesson declares $0.82 dividend
McKesson (MCK) Expected to Announce Earnings on Wednesday
311 Shares in McKesson Corporation $MCK Purchased by SYM FINANCIAL Corp
US appeals court overturns West Virginia landmark opioid lawsuit decision
This ‘Strong Buy’ Healthcare Stock Just Hit New All-Time Highs
UBS Maintains McKesson (MCK) Buy Recommendation
This report was written by MarketBeat.com on October 30, 2025. This report first appeared on MarketBeat.com.